RxDoctor Payments Data

Bruce Carpenter, MD

Family Medicine · Granbury, TXNPI 1346298031

Payments from drug & device makers

$1,260in general payments, 2019–2025

Across 73 payments — averaging $17.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$395
  • Amgen$159
  • AbbVie$156
  • Lilly USA, LLC$95
  • Pfizer$74
  • Merck$62
  • plus $319 from 10 others

What the payments were for

  • Food & beverage$1,260100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,260 in reported general payments places this provider in the 65th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$513,386
Medicare patients
954
Services billed
10,397

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban166$165,590
JanuviaSitagliptin Phosphate83$82,895
Trelegy ElliptaFluticasone/Umeclidin/Vilanter103$79,728
JardianceEmpagliflozin46$43,927
FarxigaDapagliflozin Propanediol55$40,318
XareltoRivaroxaban36$30,493
ProliaDenosumab18$30,237
MyrbetriqMirabegron37$29,356
OzempicSemaglutide27$27,302
MounjaroTirzepatide13$13,264
Breo ElliptaFluticasone/Vilanterol25$12,984
Spiriva HandihalerTiotropium Bromide14$8,795
Breztri AerosphereBudesonide/Glycopyr/Formoterol13$7,568
Incruse ElliptaUmeclidinium Bromide15$6,642
Levothyroxine Sodium527$6,503

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$74$165,590166 claims
GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta, Arexvy$31$105,380164 claims
MerckJanuvia, Janumet Xr$62$89,31295 claims
AstraZenecaFarxiga, Breztri Aerosphere$48$47,88668 claims
Boehringer IngelheimJardiance$56$43,92746 claims
AmgenProlia$159$30,23718 claims
Novo NordiskOzempic$395$27,30227 claims
Lilly USA, LLCMounjaro$95$13,26413 claims
AbbVieSynthroid$156$2,85466 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Granbury

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →